AdvaCare Pharma

What AdvaCare Pharma does

AdvaCare Pharma is a privately-held pharmaceutical and healthcare product manufacturer operating a B2B distribution model. The company produces and supplies more than 4,000 medical products across four divisions — pharmaceuticals (500+ products across 13 dosage forms including antibiotics, anti-diabetics, and oncology), medical devices (500+ Class I & II devices spanning diagnostics, injection instruments, disposables, wound care, and incontinence), supplements (150+ nutritional formulations), and veterinary products (250+ generics, custom formulations, and pet supplements). Manufacturing is conducted across multiple GMP-certified facilities in the United States, China, India, Malaysia, and Vietnam, and the company maintains ISO 13485:2016, CE, US FDA 510(k), WHO-COPP, GDP, HACCP, NSF, and BRC certifications across product lines. The firm maintains a regulatory affairs backbone that pre-builds and continuously updates CTD/eCTD dossiers for 500+ products, including Zone IVb stability data and bioequivalence studies, intended to compress distributor registration timelines by 3-6 months and avoid 150-day RFI correction delays.

The business model is exclusively B2B: products are sold in bulk to vetted medical distributors, hospitals, pharmacies, and institutions under multi-year Distribution Agreements with FOB incoterms and 30-60 day standard lead times. Pricing is governed by an ethical pricing policy tied to API, raw material, and FX inputs, with standard wholesale discounts of 40-50% off MSRP and strictly enforced Minimum Advertised Price (MAP) policies. The company also selectively provides contract manufacturing (CMO/CDMO) services for distributors requiring custom formulations. Go-to-market is channel-led through a "vested supplier-distributor relationship" supported by marketing materials, strategic planning, on-the-ground training, and exclusive territorial rights in approved markets.

The firm is headquartered in Cheyenne, United States, with disclosed operational presence in 65+ countries across Asia, Africa, Latin America & Caribbean, Middle East, CIS, East Europe, and Oceania. Branded sub-portfolios include AccuQuik, AccuPoint, StaySafe, StayGuard, StayDry, AdvaLife, AdvaMate, and pharmaceutical brands CeftriCare, MetroCare, MetCare, GlimeCare, AmoxiCare, CalCare, CeftamCare, and VitB12Care. Leadership disclosure is thin — only Ryan Vitanza (VP of Global Sales) is named in the input. Financials, headcount detail beyond 51-100 band, ownership structure, and funding history are not disclosed.

Name

AdvaCare Pharma

Legal name

AdvaCare Pharma

Website

https://advacarepharma.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

AdvaCare Pharma is a private US-domiciled manufacturer of pharmaceuticals, medical devices, supplements, and veterinary products, supplying 4,000+ SKUs exclusively on a B2B basis to vetted medical distributors, hospitals, pharmacies, and institutions across 65+ countries.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Generic Hospital & Institutional Products (HLAIABAL), OTC & Consumer Health Distributors (HLAIAJAC), Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Generic pharmaceuticals manufacturing
• Medical devices manufacturer
• Veterinary pharmaceuticals supply
• Dietary supplements production
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Cheyenne

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. B2B Pharmaceutical Distribution: AdvaCare Pharma manufactures and sells products in bulk exclusively to medical distributors, hospitals, pharmacies, and institutions. The company produces over 4,000 medical products across pharmaceuticals, medical devices, supplements, and veterinary categories. Revenue is generated through product sales with payment terms varying by country, distributor, and order specifics as defined in Distribution Agreements.
2. Contract Manufacturing (CMO/CDMO): The company provides some CMO services depending on distributor and market requirements, with CDMO services available for distributors and markets requiring specific formulations or customized products for increased market adaptation. The majority of manufacturing capacity is allocated for AdvaCare Pharma brands.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

AdvaCare Pharma manufactures and distributes more than 4,000 medical products globally across four divisions: pharmaceuticals (500+ products), medical devices (500+ Class I and II devices), supplements (150+ products), and veterinary medicines (250+ formulations). Products are sold exclusively in bulk to medical distributors, hospitals, pharmacies, and institutions through a vetted B2B distribution network spanning 65+ countries, supported by GMP and ISO 13485 manufacturing across facilities in the US, China, India, Malaysia, and Vietnam. The company also provides selective contract manufacturing (CMO/CDMO) services for distributors requiring custom formulations.

Product overview

AdvaCare Pharma is a pharmaceutical and healthcare manufacturer and distributor offering more than 4,000 medical products globally. The portfolio is organized into four main product divisions: Pharmaceuticals (500+ products across 13 dosage forms including CeftriCare antibiotics, MetroCare anti-infectives, MetCare and GlimeCare diabetes treatments, and CalCare/VitB12Care nutritional products), Medical Devices (500+ Class I & II devices including AccuPoint injection instruments, AccuQuik diagnostic tests, StaySafe disposables, StayGuard wound care, and StayDry incontinence products), Supplements (150+ products in 9 dosage forms under AdvaLife including Omega-3 and multivitamins), and Veterinary (250+ formulations in 13 dosage forms including AdvaMate pet supplements, Ivermectin and Oxytetracycline injections). The company operates a B2B distribution model selling exclusively to medical distributors, hospitals, pharmacies, and institutions across 65+ countries, with manufacturing facilities in the US, China, India, Malaysia, and Vietnam.

Differentiator

Problem solved

Functional benefit

Brands

• AccuQuik: Diagnostic detection products including pregnancy test kits and diagnostic test kits
• AccuPoint
• StaySafe
• StayGuard
• StayDry
• AdvaLife
• AdvaMate
• CeftriCare
• MetroCare
• MetCare
• GlimeCare
• AmoxiCare
• CeftamCare
• CalCare
• VitB12Care

Products and services

• Pharmaceuticals Division Therapies to cure diseases and intervene in chronic illnesses, comprising 500+ products across 13 dosage forms including common generics, specialty generics, OTC, and oncology medications, sold in bulk to medical distributors, hospitals, and pharmacies.
• Medical Devices Division Medical devices including diagnostic detection products, medical wear, injection instruments, and wound care supplies, comprising 500+ Class I and II devices with 1M+ specification options for distributors and institutional buyers.
• Supplements Division Vitamins, minerals, and herbal formulations including general health, condition-specific, and herbal products, with 150+ scientifically-formulated nutritional products manufactured in 9 dosage forms, sold in bulk to distributors and retailers.
• Veterinary Division Animal health solutions for large animals and companion pets, encompassing 250+ generic and custom formulations in 13 dosage forms including veterinary generics, custom formulations, nutritional supplements, vaccines, and animal medical devices, sold in bulk to veterinary distributors.
• Contract Manufacturing (CMO/CDMO) Services Contract manufacturing services for distributors and markets requiring specific formulations or customized products, offering custom formulation development and adapted production for increased market fit.
• CeftriCare Brand (Ceftriaxone Sodium for Injection) Cephalosporin antibiotic (Ceftriaxone Sodium for Injection) sold in bulk to medical distributors and hospitals for parenteral treatment of severe bacterial infections.
• MetroCare Brand (Metronidazole Injection) Nitroimidazole antibiotic (Metronidazole Injection) supplied to distributors and hospitals for parenteral anti-infective therapy.
• MetCare Brand (Metformin HCl Tablets) First-line therapy oral antidiabetic (Metformin HCl Tablets) supplied to distributors and pharmacies for type 2 diabetes management.
• GlimeCare Brand (Glimepiride Tablets) Oral sulfonylurea antidiabetic (Glimepiride Tablets) supplied in bulk to medical distributors for type 2 diabetes management.
• AmoxiCare Brand (Amoxicillin Capsules) Penicillin-class antibiotic (Amoxicillin Capsules) supplied in bulk to distributors and pharmacies for treatment of bacterial infections.
• CeftamCare Brand (Ceftriaxone + Sulbactam for Injection) Combination cephalosporin-beta-lactamase inhibitor antibiotic (Ceftriaxone + Sulbactam for Injection) supplied in bulk for parenteral antibacterial therapy.
• CalCare Brand (Calcium Chloride Injection) Electrolyte replacement pharmaceutical (Calcium Chloride Injection) supplied in bulk to distributors and hospitals.
• VitB12Care Brand (Vitamin B12 Injection) Injectable vitamin supplement (Vitamin B12 Injection) supplied in bulk to distributors for nutritional and therapeutic use.
• AccuPoint Brand (Injection Precision Instruments) ISO 13485 certified injection instruments including auto-disable syringes, safety syringes, control syringes, IV cannulas, blood transfusion bags, and EVA infusion bags, sold in bulk to distributors and institutional buyers.
• AccuQuik Brand (Diagnostic Supplies) ISO 13485 certified diagnostic detection products including pregnancy test kits and other rapid diagnostic test kits for clinical detection, sold in bulk to distributors.
• StaySafe Brand (Medical Disposables) Medical disposables for healthcare safety including syringes and other single-use medical supplies, sold in bulk to distributors and hospitals.
• StayGuard Brand (Skin and Wound Care) Skin and wound care medical supplies sold in bulk to distributors, hospitals, and clinics.
• StayDry Brand (Incontinence Supplies) Incontinence and urology medical supplies for urinary incontinence management, sold in bulk to distributors and institutional buyers.
• AdvaLife Brand (Nutritional Supplements) Nutritional supplement brand including Omega-3 capsules and other scientifically formulated health products, sold in bulk to distributors and retailers.
• AdvaMate Brand (Pet Supplements) Pet health supplements including hip and joint soft chews, digestive support, probiotics, skin and coat care, and multivitamin supplements for dogs and other companion animals, sold in bulk to veterinary distributors, pet shops, and veterinary clinics.

Quantifiable outcome

• Reduces pharmaceutical registration preparation time by 3-6 months through pre-built CTD dossiers
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mankind Pharma: Indian generic pharmaceutical manufacturer with a broad portfolio across dosage forms, distributing globally including emerging markets. Closely comparable to AdvaCare in its generic-pharma manufacturing focus and multi-country B2B distribution model.
• Macleods Pharmaceuticals: India-based generic pharmaceutical manufacturer offering formulations across multiple therapeutic categories, with strong presence across Africa, Asia, and Latin America. Highly comparable to AdvaCare's emerging-market generic-pharma distribution model.
• Cipla: Indian global pharmaceutical company focused on generics and complex formulations across respiratory, antiretroviral and other therapeutic categories, with deep emerging-market presence. Directly comparable to AdvaCare's generic-pharma/export B2B model.
• Alkem Laboratories: Indian generic pharmaceutical manufacturer with multi-country distribution, portfolio spanning tablets, injectables and OTCs. Comparable in scope of generics manufacturing, dosage forms, and emerging-market distribution.
• Lupin Pharmaceuticals: India-based generic and specialty pharmaceutical manufacturer with a global commercial footprint including emerging markets. Comparable generic-pharma manufacturing and multi-region distribution.
• Zydus Lifesciences: Indian pharmaceutical manufacturer producing generics, APIs, and consumer healthcare products across dosage forms for global markets. Comparable manufacturing breadth and multi-country distribution profile.
• Apotex: Canadian-headquartered generic pharmaceutical manufacturer producing finished-dose generics for global markets including developing regions. Overlaps with AdvaCare on generic manufacturing, dosage-form breadth, and multi-jurisdictional regulatory positioning.

Broad incumbents

• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with a broad API-to-finished-dose portfolio and global distribution. Significantly larger than AdvaCare, but overlaps meaningfully in generic manufacturing across many of the same dosage forms and emerging markets.
• Teva Pharmaceutical Industries: One of the world's largest generic pharmaceutical manufacturers with a global distribution network. Overlaps broadly with AdvaCare's generic-pharma manufacturing and emerging-market reach, but operates at a substantially larger scale.

Emerging players

• Recipharm: Global contract development and manufacturing organization (CDMO) offering sterile injectables and other pharmaceutical manufacturing services. Comparable to AdvaCare's CMO/CDMO service line and injectables manufacturing capability.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AdvaCarePharmaUSA
• LinkedInlinkedin.com/company/advacare-pharmaceuticals
• Xx.com/advacareafrica

Compliance16 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AdvaCare Pharma